Diversify Wealth Management’s AtriCure ATRC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$318K Buy
11,631
+2,476
+27% +$84.5K 0.01% 941
2025
Q4
$333K Sell
9,155
-148
-2% -$5.43K 0.02% 514
2025
Q3
$317K Sell
9,303
-570
-6% -$19.6K 0.02% 449
2025
Q2
$354K Sell
9,873
-482
-5% -$15.7K 0.02% 426
2025
Q1
$359K Sell
10,355
-243
-2% -$9.02K 0.03% 412
2024
Q4
$333K Sell
10,598
-267
-2% -$8.59K 0.03% 419
2024
Q3
$313K Sell
10,865
-1,089
-9% -$26.8K 0.03% 389
2024
Q2
$256K Buy
+11,954
New +$276K 0.03% 382

Other funds holding ATRC

Diversify Wealth Management's ATRC Position: Q1 2026 in Review

Diversify Wealth Management increased its AtriCure (ATRC) stake by 27% in Q1 2026, buying an estimated $84.5K and bringing the position to 11,631 shares worth $318K. The position accounts for 0.01% of the portfolio, ranked #941.

Diversify Wealth Management first reported a position in ATRC in Q2 2024 and has held it in 8 quarters since. The position peaked at $359K in Q1 2025. 223 funds tracked by Wall St. Rank hold ATRC as of Q1 2026.

  • Diversify Wealth Management held 11,631 shares of AtriCure worth $318K as of Q1 2026.
  • Diversify Wealth Management bought 2,476 AtriCure shares in Q1 2026, an estimated $84.5K.
  • AtriCure made up 0.01% of Diversify Wealth Management's portfolio in Q1 2026, its #941 holding.
  • Diversify Wealth Management first reported a position in AtriCure in Q2 2024 and has held it in 8 quarters since.
  • Diversify Wealth Management's AtriCure position peaked at $359K in Q1 2025.
  • 223 funds tracked by Wall St. Rank held AtriCure as of Q1 2026.

Based on Diversify Wealth Management's 13F filing for Q1 2026, filed 1 May 2026.